Navigation Links
ClinStar to Present on Clinical Trial Recruitment in the Emerging Regions of Russia and Eastern Europe
Date:10/18/2011

SAN FRANCISCO, Oct. 18, 2011 /PRNewswire/ -- ClinStar, LLC, an established CRO providing clinical research services in Russia and Eastern Europe to the pharmaceutical and biotechnology industry, announced today that President and CEO David Passov and Manager of Clinical Operations Alexander Kutermin will speak at Global Engage's 3rd Oncology Clinical Trials in Emerging Regions conference, November 3-4, in Philadelphia, PA.  

(Logo:  http://photos.prnewswire.com/prnh/20110719/SF36975LOGO)

According to the International Agency for Research on Cancer's (a division of the World Health Organization) GLOBOCAN 2008 report, an estimated 12.7 million people worldwide are diagnosed with some form of cancer annually and this number is expected to jump to 21 million by 2030. The emerging markets of Russia, Ukraine, Belarus and the Baltics offer access to a population of more than five million cancer sufferers. By conducting clinical trials in these regions, biopharmaceutical companies can significantly speed enrollment, and thereby, reduce the overall time and cost to develop an oncology drug.  

During the presentation scheduled for Friday, November 4 at 1:30 p.m., Mr. Passov will explore perceptions and comparisons of emerging markets and discuss how to navigate cultural and regulatory challenges in the region in order to optimize recruitment. Mr. Kutermin will present a case study revealing how Russia, Ukraine, Belarus and the Baltics outperformed 20+ other countries in a global, Phase III breast cancer trial.  

Through a series of keynote regional presentations, case studies and interactive panel discussions, Global Engage's 3rd Oncology Clinical Trials in Emerging Regions conference will examine the current role that emerging regions play in conducting oncology clinical trials with a focus on the operational, regulatory and logistical challenges involved.  

About ClinStar, LLC

ClinStar is one of the most prominent CROs in the emerging markets of Eastern Europe and the Baltics with more than 10 years of expertise in Phase I-IV clinical studies in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages studies from its offices in Russia, Ukraine and Belarus, with total staff of over 260 people. Its portfolio contains over 130 clinical trials conducted for US and European pharmaceutical and biotechnology companies. More information is available at www.clinstar.com.


'/>"/>
SOURCE ClinStar, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ClinStar to Present on Russias Performance as an Emerging Market in Global Clinical Trials
2. ClinStar to Present on Conducting Clinical Trials in Russia
3. ClinStar, LLC Establishes New Office on the US East Coast
4. Pacira Pharmaceuticals, Inc. Announces Key EXPAREL™ Data to be Presented at American College of Surgeons 97th Annual Clinical Congress
5. Renessa® Treatment for Stress Incontinence: Three Year Clinical Results Presented
6. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
7. Good Start Genetics to Announce Validation Study Results for its Next-Generation DNA Sequencing Platform During an Oral Presentation at the 2011 Annual Meeting of the American Society for Reproductive Medicine (ASRM)
8. PLC Medical Systems CEO Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Alexza Pharmaceuticals to Present at the 18th Annual NewsMakers in the Biotech Industry Conference
10. Ziehm Imaging Presents new 20 kW Ziehm Vision R
11. Amerigroup Foundation Presents Grant to Rx Partnership in Virginia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... YORK , Feb. 21, 2017 ... industry. This technique is allowing a previously unattainable ... simplicity. Due to this ability, it is anticipated ... cross US$ 4 Billion by 2022. The growth ... by advancements in computing platforms, rising installation of ...
(Date:2/21/2017)... -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the leader in ... release its fourth quarter and full year 2016 financial ... 2017. The press release will be followed by a ... open to the public via telephone and webcast. During ... results and provide a business update. The ...
(Date:2/21/2017)... FALLS, Idaho , Feb. 21, 2017  International ... has completed a private placement with certain investors for ... stock of the Company, Series C Convertible Redeemable Preferred ... accrues dividends at an annual rate of 6% and ... The Company plans to use the proceeds for operating ...
Breaking Medicine Technology:
(Date:2/21/2017)... ... , ... Doctors on Liens has announced the addition of Mendonca Spine ... its growing network of doctors in Central and Northern California. Dr. Mendonca specializes in ... whiplash, back pain, neck pain, hip and knee pain, and headaches. Specializing in ...
(Date:2/21/2017)... ... 2017 , ... Individuals who have been diagnosed with cancer ... therapy and management. Regular exercise in proper environments has been shown to benefit ... On February 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx webinar ...
(Date:2/21/2017)... , ... February 21, 2017 , ... Support of value-based ... simplify the secure exchange of data across industry solutions, Fogo Data Centers announces the ... of community. A healthy community is one in which all systems work well, ...
(Date:2/21/2017)... ... February 21, 2017 , ... Bioclinica®, ... expansion of its eHealth App xChange™, providing clinical researchers more choices in ... and growing eHealth platform. Applications that enable patient-centered clinical trials make up ...
(Date:2/21/2017)... ... 2017 , ... Atlanta-based Jvion, the leading cognitive clinical science ... practice. Predixion, which raised $42M+ to date, received $20M in its third ... Ventures, and Software AG , will bring top industry talent and an impressive ...
Breaking Medicine News(10 mins):